Inventor · disambiguated record
Junjie Liu
Also filed as: LIU JUNJIE
39 granted patents·21 pending applications·666 citations·filing 2003–2024
98Inventor score
Files withAMBRX INC17AVELAS BIOSCIENCES INC16MIAO ZHENWEI10SCHERER TECHNOLOGIES LLC R P3RADIONETICS ONCOLOGY INC2
Top patents by PatentIndex Score
60 records- 0199US7696312B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Apr 13, 2010·63 cites·17 claims
- 0299US7638491B2Therapies using non-natural amino acids and polypeptidesAMBRX INC·Filed 2005·Granted Dec 29, 2009·40 cites·6 claims
- 0399US7385028B2Derivatization of non-natural amino acids and polypeptidesAMBRX INC·Filed 2005·Granted Jun 10, 2008·91 cites·20 claims
- 0499US7332571B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2005·Granted Feb 19, 2008·101 cites·6 claims
- 0598US8809511B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesMIAO ZHENWEI·Filed 2011·Granted Aug 19, 2014·22 cites·7 claims
- 0698US8791231B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesMIAO ZHENWEI·Filed 2011·Granted Jul 29, 2014·24 cites·1 claims
- 0798US8476411B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesMIAO ZHENWEI·Filed 2011·Granted Jul 2, 2013·36 cites·6 claims
- 0898US8008456B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Aug 30, 2011·28 cites·8 claims
- 0997US8367612B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2009·Granted Feb 5, 2013·14 cites·6 claims
- 1097US8048988B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Nov 1, 2011·28 cites·10 claims
- 1197US7928163B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Apr 19, 2011·31 cites·12 claims
- 1296US9353154B2Compositions for labeling nerves and methods of useAVELAS BIOSCIENCES INC·Filed 2015·Granted May 31, 2016·14 cites·13 claims
- 1395US9504763B2Selective delivery molecules and methods of useAVELAS BIOSCIENCES INC·Filed 2016·Granted Nov 29, 2016·8 cites·20 claims
- 1495US9371367B1Selective delivery molecules and methods of useAVELAS BIOSCIENCES INC·Filed 2016·Granted Jun 21, 2016·9 cites·19 claims
- 1595US8263740B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesMIAO ZHENWEI·Filed 2008·Granted Sep 11, 2012·20 cites·19 claims
- 1695US8153758B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesMIAO ZHENWEI·Filed 2007·Granted Apr 10, 2012·21 cites·5 claims
- 1794US8859802B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesMIAO ZHENWEI·Filed 2011·Granted Oct 14, 2014·7 cites·7 claims
- 1894US8557781B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesMIAO ZHENWEI·Filed 2007·Granted Oct 15, 2013·17 cites·12 claims
- 1993US9840537B2Selective delivery molecules and methods of useAVELAS BIOSCIENCES INC·Filed 2016·Granted Dec 12, 2017·5 cites·20 claims
- 2093US9278144B2Selective delivery molecules and methods of useLIU JUNJIE·Filed 2012·Granted Mar 8, 2016·11 cites·19 claims
- 2193US9072773B2Compositions for labeling nerves and methods of useGONZALEZ JESUS·Filed 2011·Granted Jul 7, 2015·14 cites·17 claims
- 2293US8399614B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesMIAO ZHENWEI·Filed 2007·Granted Mar 19, 2013·16 cites·3 claims
- 2389US8093356B2Pegylated human interferon polypeptidesHAYS ANNA-MARIA A·Filed 2007·Granted Jan 10, 2012·19 cites·5 claims
- 2488US9586988B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2013·Granted Mar 7, 2017·4 cites·4 claims
- 2587US10226539B2Selective delivery molecules and methods of useAVELAS BIOSCIENCES INC·Filed 2017·Granted Mar 12, 2019·4 cites·30 claims
- 2687US9782498B2Selective delivery molecules and methods of useAVELAS BIOSCIENCES INC·Filed 2014·Granted Oct 10, 2017·7 cites·32 claims
- 2786US9637441B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2014·Granted May 2, 2017·1 cites·24 claims
- 2885US10239919B2Selective delivery molecules and methods of useAVELAS BIOSCIENCES INC·Filed 2017·Granted Mar 26, 2019·1 cites·20 claims
- 2985US8846876B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesMIAO ZHENWEI·Filed 2012·Granted Sep 30, 2014·1 cites·12 claims
- 3082US11052160B2Selective delivery molecules and methods of useAVELAS BIOSCIENCES INC·Filed 2019·Granted Jul 6, 2021·1 cites·1 claims
- 3180US7135578B2Iminocyclitol inhibitors of hexoaminidase and glycosidaseSCRIPPS RESEARCH INST·Filed 2004·Granted Nov 14, 2006·7 cites·1 claims
- 3278US10994017B2Nerve labeling compositions and uses thereofAVELAS BIOSCIENCES INC·Filed 2017·Granted May 4, 2021·1 cites·2 claims
- 3376US2009111147A1Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and PolypeptidesAMBRX INC·Filed 2007·Application pending·0 cites
- 3476US2008268519A1Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and PolypeptidesAMBRX INC·Filed 2007·Application pending·0 cites
- 3574US10570178B2Selective delivery molecules and methods of useAVELAS BIOSCIENCES INC·Filed 2018·Granted Feb 25, 2020·0 cites·20 claims
- 3674US2024342303A1Sulfatase-Cleavable Linkers for Antibody-Drug ConjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2024·Application pending·0 cites
- 3771US2008268518A1Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and PolypeptidesAMBRX INC·Filed 2007·Application pending·0 cites
- 3871US2022257800A1Selective delivery molecules and methods of useAVELAS BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3967US11980668B2Sulfatase-cleavable linkers for antibody-drug conjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2019·Granted May 14, 2024·0 cites·15 claims
- 4066US2008317670A1Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and PolypeptidesAMBRX INC·Filed 2006·Application pending·0 cites
- 4166US2025064996A1Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 4265US8865658B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesMIAO ZHENWEI·Filed 2012·Granted Oct 21, 2014·0 cites·5 claims
- 4362US12275964B2Variant type V CRISPR/Cas effector polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2019·Granted Apr 15, 2025·0 cites·23 claims
- 4462US2008213840A1Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and PolypeptidesAMBRX INC·Filed 2007·Application pending·0 cites
- 4561US2025213735A1Neuropeptide y1 receptor (npy1r) targeted therapeutics and uses thereofRADIONETICS ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 4661US2023158179A1Radiopharmaceutical conjugate compositions and uses thereofRAYZEBIO INC·Filed 2022·Application pending·0 cites
- 4760US2020376013A1Selective drug delivery compositions and methods of useAVELAS BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 4858US11771774B2Nerve labeling compositions and uses thereofAVELAS ACQUISITION CORP·Filed 2021·Granted Oct 3, 2023·0 cites·9 claims
- 4958US2024226343A1Neuropeptide y1 receptor (npy1r) targeted therapeutics and uses thereofRADIONETICS ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 5057US12454685B2Variant type V CRISPR/Cas effector polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2020·Granted Oct 28, 2025·0 cites·21 claims
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Junjie Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →